Estrogenic compounds as anti-mitotic agents

Details Estrogenic compounds as anti-mitotic agents Estrogenic compounds as anti-mitotic agents

2005-08-16

2005-08-16

Kumar, S. (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S559000, C514S661000, C514S719000, C514S730000, C514S738000, C568S817000, C568S941000, C568S665000, C568S023000, C564S458000, C562S498000, C560S116000

Reexamination Certificate

active

06930128

ABSTRACT:
The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.

REFERENCES:
patent: 2584271 (1952-02-01), Huffman
patent: 2846453 (1958-08-01), Hoehn
patent: 3166577 (1965-01-01), Ringold et al.
patent: 3410879 (1968-11-01), Smith et al.
patent: 3470218 (1969-09-01), Farah
patent: 3492321 (1970-01-01), Crabbe
patent: 3496272 (1970-02-01), Kruger
patent: 3562260 (1971-02-01), De Ruggieri et al.
patent: 3956348 (1976-05-01), Hilscher
patent: 4172132 (1979-10-01), Draper et al.
patent: 4212864 (1980-07-01), Tax
patent: 4307086 (1981-12-01), Tax
patent: 4522758 (1985-06-01), Ward et al.
patent: 4552758 (1985-11-01), Murphy et al.
patent: 4634705 (1987-01-01), DeBernardis et al.
patent: 4743597 (1988-05-01), Javitt et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4994443 (1991-02-01), Folkman et al.
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5135919 (1992-08-01), Folkman et al.
patent: 5504074 (1996-04-01), D'Amato et al.
patent: 5661143 (1997-08-01), D'Amato et al.
patent: 5892069 (1999-04-01), D'Amato et al.
patent: 6528676 (2003-03-01), D'Amato et al.
patent: 1907330 (1969-10-01), None
patent: 2 004 516 (1970-09-01), None
patent: 27 57 157 (1977-12-01), None
patent: 3625315 (1988-01-01), None
patent: 0166937 (1986-08-01), None
patent: 857080 (1960-12-01), None
patent: 857081 (1960-12-01), None
patent: 1570597 (1980-07-01), None
patent: 39-5480 (1961-03-01), None
patent: 41 000100 (1966-01-01), None
patent: 42-928 (1967-01-01), None
patent: 58-131978 (1983-08-01), None
patent: 63090763 (1988-04-01), None
patent: 63-119500 (1988-05-01), None
patent: 1240038 (1996-10-01), None
patent: 87/02367 (1987-04-01), None
patent: 88/08002 (1988-10-01), None
patent: 90/15816 (1990-12-01), None
patent: 93/03729 (1993-03-01), None
patent: 93/19746 (1993-10-01), None
patent: 95/04535 (1995-02-01), None
Lilopristone/(1-[4-(Dimethylamino)phenyl]-17-hydroxy-17-(3 hydroxy-1-propenyl) estra-4, 9-diene-3-one; AK 98734Dictionary of Drugs (1990), Dict. of Steroids (1991), Dict. of Org. Cmpds (6th Ed) (1996), Dict of Pharm Agents (1997) 1990.
(paragraphs 583-584)The Merck Index 11th Editionp. 88 1989.
Research Plus Catalogpp. 50-58 1993.
Registry No. 56933-77-8Chemical Abstracts.
Registry No. 56933-77-9Chemical Abstracts.
Registry No. 57380-15-1Chemical Abstrats.
Registry No. 71782-95-1Chemical Abstracts.
Registry No. 101277-11-6Chemical Abstracts.
Aboul Wafa et al. Synthesis and evaluation for uterotrophic and antiimplantation activities of 2-substituted estradiol derivativesSteroidsvol. 57 pp. 199-204 Apr. 1992.
Adams, E. F. et al. Steroidxal regulation of oestradiol-17B dehydrogenase activity of the human breast cancer cell line MCF-7 (Chemical Abstracts Doc. No. 109:32325,Journal of Endocrinologyvol. 118(1) pp. 149-154 Jul. 1988.
Aizu-Yokota et al. Natural Estrogens Induce Modulation of Microtubules in Chinese Hamster V79 Cells in CultureCancer Researchvol. 55 pp. 1863-1868 May 01, 1995.
Algire, G. H. et al. Vascular reactions of normal and malignant tumors in vivo. 1. Vascular reactions of mice to wounds and to normal and neoplastic transplantsJournal of the National Cancer Institutevol. 6 pp. 73-85 Aug. 1945.
Aliev et al. 54929q Synthesis of cycloalkyl derivatives of dihydric phenols and their ethersChemical Abstractsvol. 72 p. 370, 1970.
Audier et al. Orientation de la fragmentation en epectrometric de masse par introduction de groupements fonctionnels. VII. -Etheylenecetals de ceto-2 steroidesBulletin De La Societe Chimique De Francevol. 10 pp. 3088-3090, 1965.
Banik et al. Orally Active Long-Acting Etrogen (AY-20,121) (3-(2--propynyloxy)-estra-1, 3, 5, (10)-triene-17. beta-o; trimethylacetate) (Identifier only)Steroidsvol. 16(3) pp. 289-296 1970.
Bardon et al. Steroid Receptor-Mediated Cytotoxicity of an Antiestrogen and an Antiprogestin in Breast Cancer Cells (Abstract only)Cancer Researchvol. 47(5) pp. 1441-1448 Mar. 01, 1987.
Barnes et al. Tumor Necrosis Factor Production in Patients with LeprosyInfection and Immunityvol. 60(4) ppl 1441-1446 Apr. 1992.
Bhat et al. Estradiol-induced Mitotic Inhibition in the Bursa of Fabricius of Male Domestic Duckling (Chemical Abstracts Doc. No: 98:31837, 1982)Mikroskopievol. 39 pp. 113-117 May 1982.
Bindra et al. Studies in Antifertility Agents.8.Seco Steroids. 2. 5,6-Secoestradiol and Some Related CompoundsJournal of Medicinal Chemistryvol. 18(9) pp. 921-925 1975.
Blickenstaff et al. Estrogen-Catharanthus (Vinca) Alkaloid Conjugates (Chemical Abstrats Doc. No: 94:114277, 1981)Cytotoxic Estrogens in Hormone Receptive Tumorspp. 89-105 1980.
Blickenstaff et al. Synthesis of Some Analogs of EstradiolSteriodsvol. 46(4, 5) pp. 889-902 Oct. 1985.
Boyce et al. Some Preliminary Synthetical Studies with 5, 6, 7, 8-Tetra-hydro-8-methylindane-1, 5-dioneUnknownpp. 4547-4553 1960.
Boye et al. 185. Deaminocolchinyl Methyl Ether: Synthesis from 2,3,4,4'-Tetramethoxybiphenyl-2-carbaldehyde. Comparison of Antitubulin Effects of Deaminocolchinyl Methyl Ether and Dehydro AnalogsHelvetica Chimica Actavol. 72 pp. 1690-1696 1989.
Brandi et al. Bone endothelial cells as estrogen targets (Abstract only)Calcif. Tissue Int.vol. 53(5) pp. 312-317 1993.
Brem, H. et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomasJournal of Neuosurgeryvol. 74 pp. 441-446 Mar. 01, 1991.
Brockway, W. J. et al. Measurement of the Binding of Antifibrinolytic Amino Acids to Various PlasminogensArchives of Biochemistry and Biophysicsvol. 151 pp. 194-199 Apr. 18, 1972.
Brosens et al. Comparative Study of the Estrogenic Effect of Ethinylestradiol and Mestranol on the EndometriumLaboratory for Gynecological Physiopathologyvol. 14(6) pp. 679-685 Dec. 01, 1976.
Browne Expression of Recombinant Human Plasminogen and Aglycoplasminogen in HeLaFibinolysisvol. 5 pp. 257-260 Apr. 13, 1991.
Cambie et al. Aromatic Steroids. Part II. Chromium Trioxide Oxidation of Some Oestra-1,3-5 (10)-trienesJournal of the Chemical Societyvol. 9 pp. 1234-1240 1969.
Cambie et al. Aromatic Steroids. Part I. Oxidation Products of 3-Methoxyestra-1,3,5(10)-triene-17βyl AcetateJ. Chem. Soc.pp. 2603-2608 1968.
Castagnetta, L. et al. Simple Approach to Measure Metabolic Pathways of Steroids in Living CellsJournal of Chromatographyvol. 572 pp. 25-39 Dec. 06, 1991.
Chasserot-Golaz et al. Biotransformation of 17.beta.-gydroxy-11. beta.-(4-dimethylaminophenyl) 17.alpha. 1-propynyl-estra-4,9-diene-3-one (RU486) in Rat Hepatoma Variants (Identifier only)Biochemical Pharmacologyvol. 46(11) pp. 2100-2103 1993.
Chen et al. A New Synthetic Route to 2-and 4-Methoxyestradiols by Nucleophilic SubstitutionSteroidsvol. 47(1) pp. 63-66 Jan. 1986.
Chen et al. Synthesis of 11. beta.-(4-dimethlaminophenyl)-17.beta-hydroxy-17.alpha.-(1-propynyl) estra-4, 9-dien-3-one (RU486) (Identifier only)Nanjing Yaoxueyuan Xuebaovol. 17(4) pp. 282-285 1986.
Cohen et al. Novel Total Synthesis of (+)-13βEthyl-3-methoxygona-1,3,5 (10)-trien-17-one, and (+)-Equilenin 3-Methyl EtherThe Journal of Organic Chemistryvol. 40(6) pp. 681-685 Mar. 21, 1975.
Collins et al. The Structure and Function of Estrogens. XI. Synthesis of (+/−)-7(8-11α)abeo-Estradiol and its 9, 11-Didehydro DerivativeAust. Journal of Chemistryvol. 45(1) pp. 71-97 1992.
Corey et al. Applications of N, N-Dimethlhydrazones to Synthesis. Use in Efficient, Positionally and Sterochemically Selective C-C Bond Formation; Oxidative Hydrolysis to Carbonyl CompoundsTetrahedron Lettersvol. 1 pp. 3-6 1976.
Corey et al. Facile Conversion of N, N-Dimethylhydrazones to Cabonyl Compounds by Cupric Ion-Catalyzed HydrolysisTetrahedron Lettersvol 41 pp. 36678-3668 1976.
Crabbe, P. Cotton effect of the styrene chromophore (Abstract only)Chem. Ind.vol. 27 pp. 917-918 1969.
Crum, R. et al. A New Class of Steroids Inhibits Angiogenesis in the Pre

Affiliated with

Also associated with

Rating

Estrogenic compounds as anti-mitotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estrogenic compounds as anti-mitotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogenic compounds as anti-mitotic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3495406